Author:
Forero-Peña David A.,Carrión-Nessi Fhabián S.,Forero-Peña José L.,Camejo-Ávila Natasha A.,Mendoza-Millán Daniela L.,Omaña-Ávila Óscar D.,Maricuto Andrea L.,Velásquez Viledy L.,Mejía-Bernard Mario D.,Rodriguez-Saavedra Carlis M.,Marcano-Rojas María V.,Contreras Yoesmir,Guerra Luis J.,Alvarado María F.,Carballo Martín,Caldera Jocays,Guevara Rafael N.,Redondo María C.,Landaeta María E.
Abstract
Abstract
Background
The coronavirus disease 2019 (COVID-19) pandemic has disrupted multiple health services, including human immunodeficiency virus (HIV) testing, care, and treatment services, jeopardizing the achievement of the Joint United Nations Programme on HIV/AIDS 90-90-90 global target. While there are limited studies assessing the impact of the COVID-19 pandemic on people living with HIV (PLHIV) in Latin America, there are none, to our knowledge, in Venezuela. This study aims to assess the impact of the COVID-19 pandemic among PLHIV seen at the outpatient clinic of a reference hospital in Venezuela.
Methods
We conducted a cross-sectional study among PLHIV aged 18 years and over seen at the Infectious Diseases Department of the University Hospital of Caracas, Venezuela between March 2021 and February 2022.
Results
A total of 238 PLHIV were included in the study. The median age was 43 (IQR 31–55) years, and the majority were male (68.9%). Most patients (88.2%, n = 210) came for routine check-ups, while 28 (11.3%) were newly diagnosed. The majority of patients (96.1%) were on antiretroviral therapy (ART), but only 67.8% had a viral load test, with almost all (95.6%) being undetectable. Among those who attended regular appointments, 11.9% reported missing at least one medical consultation, and 3.3% reported an interruption in their ART refill. More than half of the patients (55.5%) had received at least one dose of the COVID-19 vaccine, while the rest expressed hesitancy to get vaccinated. Most patients with COVID-19 vaccine hesitancy were male (65.1%), younger than 44 years (57.5%), employed (47.2%), and had been diagnosed with HIV for less than one year (33%). However, no statistically significant differences were found between vaccinated patients and those with COVID-19 vaccine hesitancy. Older age was a risk factor for missing consultations, while not having an alcoholic habit was identified as a protective factor against missing consultations.
Conclusion
This study found that the COVID-19 pandemic had a limited impact on adherence to medical consultations and interruptions in ART among PLHIV seen at the University Hospital of Caracas, Venezuela.
Publisher
Springer Science and Business Media LLC
Reference78 articles.
1. Global HIV. & AIDS statistics — 2022 Fact sheet []. https://www.unaids.org/en/resources/fact-sheet
2. MPPS OO., ONUSIDA: Tratamiento antirretroviral para personas con VIH - Guía práctica: Venezuela. In. Caracas: Ministerio del Poder Popular para la Salud de Venezuela; 2021.
3. Inzaule SC, Hamers RL, Doherty M, Shafer RW, Bertagnolio S, Rinke de Wit TF. Curbing the rise of HIV drug resistance in low-income and middle-income countries: the role of dolutegravir-containing regimens. Lancet Infect Dis. 2019;19(7):e246–52.
4. Page KR, Doocy S, Reyna Ganteaume F, Castro JS, Spiegel P, Beyrer C. Venezuela’s public health crisis: a regional emergency. Lancet. 2019;393(10177):1254–60.
5. PAHO W, UNAIDS GBJOUhtchf.: Plan maestro para El Fortalecimiento De La Respuesta Al VH, La Tuberculosis Y La malaria en la República Bolivariana de Venezuela desde una perspectiva de salud pública.